# Desonide

NDC: 45802-423
Generic name: Desonide
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: OINTMENT
Routes: TOPICAL
Marketing started: 20060822

FDA application: NDA017426

## Active ingredients

- DESONIDE: .5 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-423"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-423
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=525c035d-d54b-41c0-90c5-bcd284b1abe3